Co-Diagnostics Adds 5% In Morning Trade

On:

Shares of Co-Diagnostics, Inc. (CODX) are up more than 5% in the morning trade on Monday at $6.29.

The molecular diagnostics company today said it has shipped testing reagents for monkeypox virus to one of its international distributors.

As of July 7, 2022, over 6,000 cases of monkeypox have been reported to WHO from 59 countries, the company said.

CODX has traded in the range of $3.66-$11.82 in the past 52 weeks.

Source: Read Full Article

Lates News:
  1. Cryptos Muted Ahead Of Key Economic Data Updates
  2. Analytics Firm Santiment Highlights Market Fear as Potential Bitcoin Rebound Indicator
  3. Intuitive Machines Adds 7% On Successful Test Run Of Nova-C Lunar Lander
  4. Bitcoin Exchange Inflows Tap 6-Year Low as Investors Take Flight to Self-Custody
  5. Guidewire Rises On Improved Earnings, Above View